ArticleClinicoEconomics and outcomes research : CEOR2026
A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in Spain.
Ana Fernández et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.